Cytokinetics(CYTK.US) Officer Sells US$624.34K in Common Stock
$Cytokinetics(CYTK.US)$ Officer Blum Robert I sold 11,500 shares of common stock on Jul 10, 2024 at an average price of $54.29 for a total value of $624.34K.Source: Announcement What is statement of
Form 144 | Cytokinetics(CYTK.US) Officer Proposes to Sell 624.35K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 10, $Cytokinetics(CYTK.US)$ Officer ROBERT BLUM intends to sell 11,500 shares of its common stock on Jul 10, with a total market value of approximately $624.35K. ROBERT
Insider Sale: EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
Cytokinetics(CYTK.US) Officer Sells US$408.1K in Common Stock
$Cytokinetics(CYTK.US)$ Officer Malik Fady Ibraham sold 7,300 shares of common stock on Jul 9, 2024 at an average price of $55.9 for a total value of $408.1K.Source: Announcement What is statement
Form 144 | Cytokinetics(CYTK.US) Officer Proposes to Sell 408.12K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 9, $Cytokinetics(CYTK.US)$ Officer FADY MALIK intends to sell 7,300 shares of its common stock on Jul 9, with a total market value of approximately $408.12K. FADY MALIK
Cytokinetics(CYTK.US) Director Sells US$13,816.33 in Common Stock
$Cytokinetics(CYTK.US)$ Director Harrington Robert Arthur sold 253 shares of common stock on Jul 5, 2024 at an average price of $54.61 for a total value of $13,816.33. Source: Announcement
Express News | Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Insider Sale: Director B Parshall Sells 5,000 Shares of Cytokinetics Inc (CYTK)
Cytokinetics(CYTK.US) Director Sells US$271.1K in Common Stock
$Cytokinetics(CYTK.US)$ Director PARSHALL B LYNNE sold 5,000 shares of common stock on Jul 1, 2024 at an average price of $54.22 for a total value of $271.1K.Source: Announcement What is statement of
Cytokinetics(CYTK.US) Officer Sells US$621.58K in Common Stock
$Cytokinetics(CYTK.US)$ Officer Blum Robert I sold 11,500 shares of common stock on Jul 1, 2024 at an average price of $54.05 for a total value of $621.58K.Source: Announcement What is statement of ch
Form 144 | Cytokinetics(CYTK.US) Director Proposes to Sell 271.09K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Cytokinetics(CYTK.US)$ Director B LYNNE PARSHALL intends to sell 5,000 shares of its common stock on Jul 1, with a total market value of approximately $271.09K. B LYN
Form 144 | Cytokinetics(CYTK.US) Officer Proposes to Sell 621.62K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Cytokinetics(CYTK.US)$ Officer ROBERT BLUM intends to sell 11,500 shares of its common stock on Jul 1, with a total market value of approximately $621.62K. ROBERT BLU
Unusual Options Activity: CTLT, STX and Others Attract Market Bets, CTLT V/OI Ratio Reaches 250.0
EST Jul 1st Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.O
Cytokinetics(CYTK.US) Officer Sells US$392.14K in Common Stock
$Cytokinetics(CYTK.US)$ Officer Malik Fady Ibraham sold 7,300 shares of common stock on Jun 25, 2024 at an average price of $53.72 for a total value of $392.14K.Source: Announcement What is statement
Form 144 | Cytokinetics(CYTK.US) Officer Proposes to Sell 392.17K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 25, $Cytokinetics(CYTK.US)$ Officer FADY MALIK intends to sell 7,300 shares of its common stock on Jun 25, with a total market value of approximately $392.17K. FADY MALIK
Cytokinetics Is Maintained at Overweight by JP Morgan
Cytokinetics Is Maintained at Overweight by JP Morgan
JP Morgan Maintains Overweight on Cytokinetics, Lowers Price Target to $65
JP Morgan analyst Tessa Romero maintains Cytokinetics (NASDAQ:CYTK) with a Overweight and lowers the price target from $77 to $65.
J.P. Morgan Maintains Cytokinetics(CYTK.US) With Buy Rating, Announces Target Price $65
J.P. Morgan analyst Tessa Romero maintains $Cytokinetics(CYTK.US)$ with a buy rating, and sets the target price at $65.According to TipRanks data, the analyst has a success rate of 50.0% and a total a
Express News | Cytokinetics Inc : JP Morgan Cuts Target Price to $65 From $77
Unusual Options Activity: DDOG, BABA and Others Attract Market Bets, DDOG V/OI Ratio Reaches 162.5
EST Jun 21st Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trend